HENRY JOHANSSON, M.D.; IVAR WERNER, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In a report from an NIH Conference (1973) on primary hyperparathyroidism Dr. Mallette (1) states that the last 8 years' cases of this condition had a surprisingly high prevalence of unexplained anemia and elevated sedimentation rate. Malignancies and other plausible causes for these findings were looked for, but "screening tests" came out normal. A connection between parathyroid hyperactivity and malignant disease has previously been suggested by Kohout (2).
In the Uppsala University Hospital we have seen about 350 cases of surgically proved primary hyperparathyroidism during the last 15 years. Among these cases, coexisting malignant disease was found
JOHANSSON H, WERNER I. Dysproteinemia, Malignancy, and Hyperparathyroidism. Ann Intern Med. ;83:121–122. doi: 10.7326/0003-4819-83-1-121_2
Download citation file:
Published: Ann Intern Med. 1975;83(1):121-122.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use